Arvinas
IPO
- Headquarters
- New Haven, Connecticut
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Website
- arvinas.com
- Total Funding
- $464.9M
- Last Round
- $350.0M Private EquityNov 2023
About
Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurodegenerative diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account